119 related articles for article (PubMed ID: 23660586)
1. Cetuximab therapy in the treatment of metastatic colorectal cancer: the future frontier?
Gomez D; De Rosa A; Addison A; Brooks A; Malik HZ; Cameron IC
Int J Surg; 2013; 11(7):507-13. PubMed ID: 23660586
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
[TBL] [Abstract][Full Text] [Related]
3. Optimum chemotherapy regimens for neoadjuvant therapy of hepatic colorectal metastases.
Davies JM; Goldberg RM
J Surg Oncol; 2010 Dec; 102(8):946-54. PubMed ID: 21165997
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of cetuximab in therapy of metastatic colorectal cancer: a system evaluation].
Hou SH; Liang XB; Bai WQ; Yang J; Yan D; Zhang X; Wang LC
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1387-90. PubMed ID: 19671328
[TBL] [Abstract][Full Text] [Related]
5. Controversies in antiepidermal growth factor receptor therapy in metastatic colorectal cancer.
Woo J; Palmisiano N; Tester W; Leighton JC
Cancer; 2013 Jun; 119(11):1941-50. PubMed ID: 23504768
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of cetuximab in metastatic colon cancer - case report.
Grigorean VT; Ciuhu AN; Rahnea Nita G; Strambu V; Straja DN; Popescu M; Sandu AM; Rahnea Nita RA
Chirurgia (Bucur); 2014; 109(3):383-9. PubMed ID: 24956345
[TBL] [Abstract][Full Text] [Related]
7. Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.
Wong SF
Clin Ther; 2005 Jun; 27(6):684-94. PubMed ID: 16117976
[TBL] [Abstract][Full Text] [Related]
8. The role of chemotherapy in managing patients with resectable liver metastases.
Halfdanarson TR; Kendrick ML; Grothey A
Cancer J; 2010; 16(2):125-31. PubMed ID: 20404609
[TBL] [Abstract][Full Text] [Related]
9. [Specific treatment situations in metastatic colorectal cancer].
Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
[TBL] [Abstract][Full Text] [Related]
10. [A case report of conversion therapy for initially unresectable colorectal cancer liver metastases after cetuximab as third-line treatment].
Hamamoto Y; Komaki T; Miyamoto J; Akutsu N; Warita E; Yamanaka Y; Kuroki Y; Shirakawa H; Ozawa H; Tomikawa M; Hishinuma S; Hoshi S; Igarashi S; Ozasa T; Sugano Y; Kotake K
Gan To Kagaku Ryoho; 2011 Jun; 38(6):1017-9. PubMed ID: 21677499
[TBL] [Abstract][Full Text] [Related]
11. Cetuximab in the first-line therapy of metastatic colorectal carcinoma: not so CRYSTAL clear.
Windsor AC; Cohen R; Jiao LR; Stebbing J
Future Oncol; 2008 Dec; 4(6):741-4. PubMed ID: 19086837
[No Abstract] [Full Text] [Related]
12. Optimizing resection for "responding" hepatic metastases after neoadjuvant chemotherapy.
Thomay AA; Charpentier KP
J Surg Oncol; 2010 Dec; 102(8):1002-8. PubMed ID: 20734423
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases.
Brouquet A; Nordlinger B
Scand J Gastroenterol; 2012 Mar; 47(3):286-95. PubMed ID: 22182353
[TBL] [Abstract][Full Text] [Related]
14. [Colorectal cancer liver metastases -- neoadjuvant concepts for preoperative down-sizing].
Golling M; Gog C; Woeste G; Zapletal C; Wullstein C; Bechstein WO
Zentralbl Chir; 2006 Apr; 131(2):140-7. PubMed ID: 16612781
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of liver metastasis from colorectal cancer].
Bismuth H; Adam R; Vibert E
Bull Acad Natl Med; 2007 Nov; 191(8):1647-60; discussion 1660. PubMed ID: 18666464
[TBL] [Abstract][Full Text] [Related]
16. Cetuximab in metastatic colorectal cancer.
Wolf I; Golan T; Shani A; Aderka D
Lancet Oncol; 2010 Apr; 11(4):313-4; author reply 314. PubMed ID: 20359660
[No Abstract] [Full Text] [Related]
17. Reversal of attachment to or invasion of major intrahepatic vessels by colorectal liver metastases according to prehepatectomy chemotherapy regimen.
Tanaka K; Nakagawa K; Yabushita Y; Hiroshima Y; Matsuo K; Ota M; Ichikawa Y; Taguri M; Tanabe M; Koda K; Endo I
Surgery; 2014 May; 155(5):936-44. PubMed ID: 24656858
[TBL] [Abstract][Full Text] [Related]
18. The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resection.
Poston G; Adam R; Xu J; Byrne B; Esser R; Malik H; Wasan H; Xu J
Eur J Surg Oncol; 2017 Nov; 43(11):2001-2011. PubMed ID: 28927777
[TBL] [Abstract][Full Text] [Related]
19. Updated options for liver-limited metastatic colorectal cancer.
Alberts SR
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S58-62. PubMed ID: 19064408
[TBL] [Abstract][Full Text] [Related]
20. Retrospective study on the effects of lipiodolization before a potentially curative hepatectomy for colorectal liver metastases: long-term results of a pilot study.
Utsunomiya T; Emi Y; Ikejiri K; Suzuki M; Saitsu H; Yakabe S; Nonaka M; Saku M; Yoshida K; Shimada M; Sugimachi K
Hepatogastroenterology; 2001; 48(39):790-3. PubMed ID: 11462925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
